New advances in hepatocellular carcinoma

Area of Science:

• Hepatology and Oncology
• Cancer Research
• Gastroenterology

Background:

• Hepatocellular carcinoma (HCC) is a primary cause of mortality in patients with liver cirrhosis and the third leading cause of cancer-related death globally.
• Risk factors for HCC predominantly include chronic viral hepatitis and alcohol abuse, leading to cirrhosis in up to 90% of cases.
• Effective prevention strategies focus on preventing new infections and managing liver disease progression in at-risk populations.

Purpose of the Study:

• To review current understanding and management strategies for hepatocellular carcinoma (HCC).
• To emphasize the importance of surveillance programs for early detection in at-risk individuals.
• To outline diagnostic criteria, staging considerations, and evidence-based treatment options for HCC.

Main Methods:

• Review of established guidelines and literature on HCC surveillance, diagnosis, staging, and treatment.
• Analysis of factors influencing treatment allocation, including liver function and tumor characteristics.
• Examination of the efficacy of various therapeutic modalities, from curative options to systemic therapy.

Main Results:

• Surveillance programs using ultrasound every six months are recommended for at-risk patients.
• Accurate staging requires consideration of both tumor burden and liver function.
• Treatment options include resection, liver transplant, interventional radiology, chemoembolization, and sorafenib for advanced disease.

Conclusions:

• Early detection through surveillance and accurate staging are critical for optimal HCC management.
• Treatment selection must be evidence-based, considering individual patient factors and disease characteristics.
• Multimodal therapeutic approaches offer the best outcomes for well-selected HCC patients.